Head and neck paraganglioma in Pacak-Zhuang syndrome

. 2025 Jan 03 ; 9 (1) : .

Jazyk angličtina Země Anglie, Velká Británie Médium print

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/pmid39821441

Grantová podpora
Eunice Kennedy Shriver National Institute of Child Health and Human Development
NCI NIH HHS - United States

BACKGROUND: Head and neck paragangliomas (HNPGLs) are typically slow-growing, hormonally inactive tumors of parasympathetic paraganglia. Inactivation of prolyl-hydroxylase domain-containing 2 protein causing indirect gain-of-function of hypoxia-inducible factor-2α (HIF-2α), encoded by EPAS1, was recently shown to cause carotid body hyperplasia. We previously described a syndrome with multiple sympathetic paragangliomas caused by direct gain-of-function variants in EPAS1 (Pacak-Zhuang syndrome, PZS) and developed a corresponding mouse model. METHODS: We evaluated a cohort of patients with PZS (n = 9) for HNPGL by positron emission tomography, magnetic resonance imaging, and computed tomography and measured carotid body size compared to literature reference values. Resected tumors were evaluated by histologic sectioning and staining. We evaluated the corresponding mouse model at multiple developmental stages (P8 and adult) for lesions of the head and neck by high resolution ex vivo imaging and performed immunohistochemical staining on histologic sections of the identified lesions. RESULTS: hree patients had imaging consistent with HNPGL, one of which warranted resection and was confirmed on histology. Three additional patients had carotid body enlargement (Z-score > 2.0), and 3 had carotid artery malformations. We found that 9 of 10 adult variant mice had carotid body tumors and 6 of 8 had a paraganglioma on the cranio-caval vein, the murine homologue of the superior vena cava; these were also found in 4 of 5 variant mice at post-natal day 8. These tumors and the one resected from a patient were positive for tyrosine hydroxylase, synaptophysin, and chromogranin A. Brown fat in a resected patient tumor carried the EPAS1 pathogenic variant. CONCLUSIONS: These findings (1) suggest HNPGL as a feature of PZS and (2) show that these pathogenic variants are sufficient to cause the development of these tumors, which we believe represents a continuous spectrum of disease starting from hyperplasia.

Center for Adrenal Endocrine Tumors AKESO Prague 5 Czech Republic

Clinical Pathology and Laboratory Medicine Indiana University School of Medicine Indianapolis IN United States

Department of Otolaryngology Georgetown University School of Medicine Washington DC United States

Department of Radiology George Washington University Washington DC United States

Division of Endocrinology Diabetes and Metabolism Tufts Medical Center Boston MA United States

Division of Solid Tumor St Jude Children's Research Hospital Memphis TN United States

General Surgical Pathology Section National Institutes of Health Bethesda MD United States

Laboratory of Vascular and Matrix Genetics National Heart Lung and Blood Institute National Institutes of Health Bethesda MD United States

MedPix® National Library of Medicine Bethesda MD United States

Mouse Imaging Facility National Institute of Neurological Disorders and Stroke National Institutes of Health Bethesda MD United States

National Institute of Diabetes and Digestive and Kidney Diseases National Institutes of Health Bethesda MD United States

Neuro Oncology Branch National Cancer Institute National Institutes of Health Bethesda MD United States

Office of Clinical Director National Institute on Deafness and Other Communication Disorders Bethesda MD United States

Section on Medical Neuroendocrinology Eunice Kennedy Shriver National Institute of Child Health and Human Development National Institutes of Health Bethesda MD United States

Surgical Neurology Branch National Institute of Neurological Disorders and Stroke National Institutes of Health Bethesda MD United States

Zobrazit více v PubMed

Därr R, Nambuba J, Del Rivero J, et al.  Novel insights into the polycythemia-paraganglioma-somatostatinoma syndrome. Endocr Relat Cancer. 2016;23:899-908. PubMed PMC

Pacak K, Jochmanova I, Prodanov T, et al.  New syndrome of paraganglioma and somatostatinoma associated with polycythemia. J Clin Oncol. 2013;31:1690-1698. PubMed PMC

Semenza GL.  Hypoxia-inducible factors in physiology and medicine. Cell. 2012;148:399-408. PubMed PMC

Zhuang Z, Yang C, Lorenzo F, et al.  Somatic HIF2A gain-of-function mutations in paraganglioma with polycythemia. N Engl J Med. 2012;367:922-930. PubMed PMC

Chowdhury R, Leung IKH, Tian Y-M, et al.  Structural basis for oxygen degradation domain selectivity of the HIF prolyl hydroxylases. Nat Commun. 2016;7:12673. PubMed PMC

Kaelin WG Jr, Ratcliffe PJ.  Oxygen sensing by metazoans: the central role of the HIF hydroxylase pathway. Mol Cell. 2008;30:393-402. PubMed

Dunwoodie SL.  The role of hypoxia in development of the mammalian embryo. Dev Cell. 2009;17:755-773. PubMed

Scully D, Keane E, Batt E, et al.  Hypoxia promotes production of neural crest cells in the embryonic head. Development. 2016;143:1742-1752. PubMed

Niklasson CU, Fredlund E, Monni E, et al.  Hypoxia inducible factor-2alpha importance for migration, proliferation, and self-renewal of trunk neural crest cells. Dev Dyn. 2021;250:191-236. PubMed PMC

Richter S, Qiu B, Ghering M, et al.  Head/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine. Endocr Relat Cancer. 2022;29:213-224. PubMed PMC

Neumann HPH, Sullivan M, Winter A, et al.  Germline mutations of the TMEM127 gene in patients with paraganglioma of head and neck and extraadrenal abdominal sites. J Clin Endocrinol Metab. 2011;96:E1279-E1282. PubMed

Boedeker CC, Erlic Z, Richard S, et al.  Head and neck paragangliomas in von Hippel-Lindau disease and multiple endocrine neoplasia type 2. J Clin Endocrinol Metab. 2009;94:1938-1944. PubMed PMC

Hussain I, Husain Q, Baredes S, et al.  Molecular genetics of paragangliomas of the skull base and head and neck region: implications for medical and surgical management. J Neurosurg. 2014;120:321-330. PubMed

Fielding JW, Hodson EJ, Cheng X, et al.  PHD2 inactivation in type I cells drives HIF-2alpha-dependent multilineage hyperplasia and the formation of paraganglioma-like carotid bodies. J Physiol. 2018;596:4393-4412. PubMed PMC

Maxwell PH, Wiesener MS, Chang GW, et al.  The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature. 1999;399:271-275. PubMed

Yu F, White SB, Zhao Q, Lee FS.  HIF-1alpha binding to VHL is regulated by stimulus-sensitive proline hydroxylation. Proc Natl Acad Sci U S A. 2001;98:9630-9635. PubMed PMC

Yang C, Sun MG, Matro J, et al.  Novel HIF2A mutations disrupt oxygen sensing, leading to polycythemia, paragangliomas, and somatostatinomas. Blood. 2013;121:2563-2566. PubMed PMC

Wang H, Cui J, Yang C, et al.  A transgenic mouse model of Pacak(-)Zhuang syndrome with an Epas1 gain-of-function mutation. Cancers (Basel). 2019;11:667. PubMed PMC

Rosenblum JS, Cappadona AJ, Argersinger DP, et al.  Neuraxial dysraphism in EPAS1-associated syndrome due to improper mesenchymal transition. Neurol Genet. 2020;6:e414. PubMed PMC

Nguyen RP, Shah LM, Quigley EP, et al.  Carotid body detection on CT angiography. AJNR Am J Neuroradiol. 2011;32:1096-1099. PubMed PMC

Rosenblum JS, Wang H, Dmitriev PM, et al.  Developmental vascular malformations in EPAS1 gain-of-function syndrome. JCI Insight. 2021;6. PubMed PMC

Streeter GL.  The developmental alterations in the vascular system of the brain of the human embryo. Contrib Embryol. 1918;8:7-38.

Di Franco A, Guasti D, Mazzanti B, et al.  Dissecting the origin of inducible brown fat in adult humans through a novel adipose stem cell model from adipose tissue surrounding pheochromocytoma. J Clin Endocrinol Metab. 2014;99:E1903-E1912. PubMed

Lam AK.  Update on adrenal tumours in 2017 World Health Organization (WHO) of endocrine tumours. Endocr Pathol. 2017;28:213-227. PubMed

Mete O, Asa SL, Gill AJ, et al.  Overview of the 2022 WHO classification of paragangliomas and pheochromocytomas. Endocr Pathol. 2022;33:90-114. PubMed

Erickson AG, Kameneva P, Adameyko I.  The transcriptional portraits of the neural crest at the individual cell level. Semin Cell Dev Biol. 2023;138:68-80. PubMed PMC

Kastriti ME, Kameneva P, Kamenev D, et al.  Schwann cell precursors generate the majority of chromaffin cells in Zuckerkandl organ and some sympathetic neurons in paraganglia. Front Mol Neurosci. 2019;12:6. PubMed PMC

Kameneva P, Artemov AV, Kastriti ME, et al.  Single-cell transcriptomics of human embryos identifies multiple sympathoblast lineages with potential implications for neuroblastoma origin. Nat Genet. 2021;53:694-706. PubMed PMC

Soldatov R, Kaucka M, Kastriti ME, et al.  Spatiotemporal structure of cell fate decisions in murine neural crest. Science. 2019;364:eaas9536. PubMed

Martik ML, Bronner ME.  Riding the crest to get a head: neural crest evolution in vertebrates. Nat Rev Neurosci. 2021;22:616-626. PubMed PMC

Abdul Sater Z, Jha A, Hamimi A, et al.  Pheochromocytoma and paraganglioma patients with poor survival often show brown adipose tissue activation. J Clin Endocrinol Metab. 2020;105:1176-1185. PubMed PMC

Tarade D, Robinson CM, Lee JE, Ohh M.  HIF-2 alpha-pVHL complex reveals broad genotype-phenotype correlations in HIF-2 alpha-driven disease. Nature Commun. 2018;9:3359. PubMed PMC

Hadi M, Chen CC, Whatley M, et al.  Brown fat imaging with (18)F-6-fluorodopamine PET/CT, (18)F-FDG PET/CT, and (123)I-MIBG SPECT: a study of patients being evaluated for pheochromocytoma. J Nucl Med. 2007;48:1077-1083. PubMed

Wang R, Gomez Salazar M, Pruñonosa Cervera I, et al.  Adipocyte deletion of the oxygen-sensor PHD2 sustains elevated energy expenditure at thermoneutrality. Nat Commun. 2024;15:7483. PubMed PMC

Jochmanova I, Pacak K.  Genomic landscape of pheochromocytoma and paraganglioma. Trends Cancer. 2018;4:6-9. PubMed PMC

Koch CA, Mauro D, Walther MM, et al.  Pheochromocytoma in von Hippel-Lindau disease: distinct histopathologic phenotype compared to pheochromocytoma in multiple endocrine neoplasia type 2. Endocr Pathol. 2002;13:17-27. PubMed

Terry M, Gupta R, Ravindranathan A, et al.  Somatic mosaic SOX10 indel mutations underlie a form of segmental schwannomatosis. Acta Neuropathol. 2023;146:857-860. PubMed PMC

Koch CA, Vortmeyer AO, Zhuang Z, et al.  New insights into the genetics of familial chromaffin cell tumors. Ann N Y Acad Sci. 2002;970:11-28. PubMed

Dmitriev PM, Wang H, Rosenblum JS, et al.  Vascular changes in the retina and choroid of patients with EPAS1 gain-of-function mutation syndrome. JAMA Ophthalmol. 2020;138:148-155. PubMed PMC

Holzenberger M, Lenzner C, Leneuve P, et al.  Cre-mediated germline mosaicism: a method allowing rapid generation of several alleles of a target gene. Nucleic Acids Res. 2000;28:E92. PubMed PMC

Rasband WS.  ImageJ. 1997-2018, U.S. National Institutes of Health.

Najít záznam

Citační ukazatele

Nahrávání dat ...

    Možnosti archivace